期刊文献+

乙型脑炎病毒减毒活疫苗生产株SA_(14)-14-2基因组全序列的测定 被引量:36

Sequence analysis of the full-length genome of Japanese encephalitis virus vaccine SA_(14)-14-2 strain
原文传递
导出
摘要 目的 对乙型脑炎减毒活疫苗SA14 1 4 2生产株进行全序列测定和分析 ,为进一步了解其基因组结构与疫苗减毒机制的关系及研究疫苗生产的遗传学质控标准奠定基础。方法 根据已发表的SA14 1 4 2株及SA14株的序列 ,设计 6对相互重叠片段的引物 ,通过RT PCR扩增出SA14 1 4 2疫苗生产株的cDNA片段 ,分别克隆到pGEM T载体 ,转化至TG1受体菌中 ,挑取阳性克隆进行鉴定后测定全序列。结果 SA14 1 4 2生产株基因组全序列长 1 0 976个核苷酸 ,96到 1 0 3 94为一个长开放读码框 ,编码 3 43 2个氨基酸。与国外测定的SA14和SA14 1 4 2株的核苷酸序列和氨基酸序列相比 ,同源性均在 99%以上 ,突变位点分散于各个区域 ,以往推测的 7个可能与减毒相关的位点均未发生改变。1 2 96~ 1 50 6间有 4个突变位点 ,有可能作为疫苗质控的遗传学标记。结论 乙脑减毒活疫苗生产株的基因组全序列基本类似于已发表的序列 ,若干不同位点产生的原因可能在于病毒株的不同传代。全序列的测定对于研究疫苗株的减毒机理及疫苗的遗传学质控标准具有一定意义。 Objective To sequence the full length genome of Japanese encephalitis virus attenuated live vaccine SA 14 14 2 strain, provide direct information about the genomic structure and the possible relationship to the attenuated mechanism, and set up the basis for investigating the genetic quality control markers of the vaccine. Methods Six pairs of overlaping primers were designed according to the published sequences of SA 14 14 2 and SA 14 strains. Using RT PCR, cDNA fragments of SA 14 14 2 strain were got and cloned into pGEM T vector, then transformed into competent TG1 hosts. Positive clones were screened, identified and sequenced. Results Sequence analysis showed that genome of JEV vaccine SA 14 14 2 strain consisted of 10976 nucleotides and contained a single open reading frame of 10299 which encoded a polyprotein of 3432 amino acids. Compared with the published sequence of SA 14 14 2 and SA 14 strain, the homology of the nucleotide sequence and deduced amino acid sequence were all more than 99%, the mutation sites were located in different regions. Seven mutation sites responsible for the attenuation deduced were all consisted in. Among them, there were 4 mutated sites between 1296 and 1506 in the E region, this region may be used as genetic markers for the quality control of the vaccine. Conclusion Sequence of SA 14 14 2 vaccine genome is similar to the published data. Some mutations are among them probably due to passage of virus in difference cultures. The sequence analysis would be helpful to understanding attenuated mechanism of the vaccine and developing genetic quality control standard for vaccine production.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2001年第5期535-539,共5页 Chinese Journal of Microbiology and Immunology
关键词 乙型脑炎病毒 SA14-14-2疫苗株 基因组 序列分析 Japanese encephalitis virus SA 14 14 2 vaccine strain Genome Sequence analysis
  • 相关文献

参考文献4

二级参考文献19

  • 1张然,岳广智,贾丽丽,俞永新.抗体捕捉ELISA法检测流行性乙型脑炎特异IgM抗体[J].中国公共卫生,1994,10(2):72-73. 被引量:2
  • 2丁志芬,常振彦,张劲锋,石慧颖,刘培生,张银凤,郭喜玲,薛亚明,耿丽华.婴幼儿对地鼠肾细胞培养乙型脑炎灭活疫苗的中和抗体应答[J].中国生物制品学杂志,1994,7(1):36-38. 被引量:7
  • 3Tsai T F,Japanese encephalitis Vaccine.In:VACCINIES.Plotkin SA,Orenstein WA eds.2nd ed,W.B.Saunders Company,Phila,1999:672
  • 4Jatanasen S.Global overwiew of Japanese Encephalitis.Southeast Asian J Trop Med Public Health.1994:26(suppl 3),4
  • 5New initiatives for the control of Japanese Encephalitis by vaccination.Minutes of the WHO/CVI/meeting Bangkok,Thailand.1998;Oct,13
  • 6WHO position paper on Japanese Encephalitis vaccines,Wkly Epidem Rec 1998:73(44):337
  • 7Hennessy S,et al.Effectiveness of live-attenuated Japanese Encephalitis vaccine (SA14-14-2):a case-control study.Lancet,1996; 347:1583
  • 8Liu Z L,el al.Shot-term safety of live attenuated Japanese Encephalitis vaccine(SA14-14-2):results of a randomized trial with 26,239 subjects.J Infect Dis.1997:176:1366
  • 9Tsai T F,et al.Immunogenicity of live attenuated SA14-14-2Japanese Encephalitis vaccine-a comparison of 1-and 3-month immunization schedules.The J Infect Dis 1998; 177:221
  • 10Sohn Y M,et al.Primary and booster immune responses to SA14-14-2 Japanese Encephalitis vaccine in Korean infants.Vaccine1999; 17:2259

共引文献45

同被引文献378

引证文献36

二级引证文献167

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部